Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.9025 0.1025 (0.26%) Market Cap: 5.68 Bil Enterprise Value: 4.87 Bil PE Ratio: 0 PB Ratio: 19.16 GF Score: 70/100

Ionis Pharmaceuticals Inc at Cowen HealthCare Conference Transcript

Mar 04, 2020 / 03:40PM GMT
Release Date Price: $54.59 (+7.63%)
Ritu Subhalaksmi Baral
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Let's go ahead and get started. Thank you, everyone, for attending the last morning of the Cowen Health Care Conference. And thanks for joining us at the Ionis fireside chat. I'm covering analyst, Ritu Baral with Cowen. And with us is CEO Brett Monia. As many of you know, Brett assumed the CEO position after being Chief Operating Officer?

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Yes. For the last couple of years.

Ritu Subhalaksmi Baral
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

For the last few years, but he assumed the CEO position on January 1 of this year as Stan has moved to the Chairman role, as Brett and I were just discussing.

I wanted to start off and give you a few minutes to review where you guys are. And maybe talk about your philosophy as CEO and how it might differ from what people have known Ionis to be.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot